Saeed Farajzadeh Valilou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Saeed Farajzadeh Valilou has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Masoud Edizadeh
Virginia Commonwealth University
2 shared publications- Afagh Alavi
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
1 shared publication Ahoura Nozari
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
1 shared publication- Arash Pooladi
Medical Genetics, School of Medicine, Research Institute for Health, Kurdistan University of Medical Sciences, Sanandaj, Iran, muk.ac.ir
1 shared publication Bijan Maghsoodlou Estrabadi
Department of Psychiatry, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
1 shared publicationBradley T. Webb
Department of Population Health Sciences, Geisinger
1 shared publication
Latest Publications
- Open Access
Rare copy number variation in alcohol use disorder using whole-genome sequencing in the All of Us Research Program
Alcohol use disorder (AUD) is common, heritable (h2 ~50%) and polygenic, but the contribution of rare structural variation is largely unexamined. Using short-read whole-genome sequencing (srWGS) data from the All of Us Research Program, we tested the association of rare copy number variants (rCNV; minor allele frequency <1%) with AUD in 56,062 participants (5,410 cases, 50,652 controls) defined from electronic health records. Analyses were conducted within European-like (EUR; N=29,392), African-like (AFR; N=8,269) and Admixed American-like (AMR; N=8,049) samples and combined by cross-ancestry meta-analysis. We tested genome-wide rCNV burden, burden within AUD-related, mouse behavioral and neuropsychiatric gene sets, and individual rCNV regions. No genome-wide burden metric or individual rCNV region ≥10 kb was associated with AUD after false discovery rate (FDR) correction. Significant gene-set results were almost exclusively duplications associated with reduced AUD risk across biologically unrelated sets, suggesting a global duplication dosage effect rather than pathway-specific enrichment. In contrast, deletion count within a Neurof_UnionStringent gene set was associated with increased AUD risk (OR=1.04, FDR=0.044), and deletions in xenobiotic-response genes showed nominal associations in multiple ancestry groups. Among rCNV of all sizes, a 58 bp deletion at 16p12.1, a dosage-sensitive neuropsychiatric locus, was significant in the cross-ancestry analysis (OR=2.93, FDR=0.030) without significant heterogeneity. rCNV detectable by srWGS do not appear to contribute substantially to AUD liability at current sample sizes.
Open AccessRare copy number variation in alcohol use disorder using whole-genome sequencing in the All of Us Research Program
Alcohol use disorder (AUD) is common, heritable (h2 ~50%) and polygenic, but the contribution of rare structural variation is largely unexamined. Using short-read whole-genome sequencing (srWGS) data from the All of Us Research Program, we tested the association of rare copy number variants (rCNV; minor allele frequency <1%) with AUD in 56,062 participants (5,410 cases, 50,652 controls) defined from electronic health records. Analyses were conducted within European-like (EUR; N=29,392), African-like (AFR; N=8,269) and Admixed American-like (AMR; N=8,049) samples and combined by cross-ancestry meta-analysis. We tested genome-wide rCNV burden, burden within AUD-related, mouse behavioral and neuropsychiatric gene sets, and individual rCNV regions. No genome-wide burden metric or individual rCNV region ≥10 kb was associated with AUD after false discovery rate (FDR) correction. Significant gene-set results were almost exclusively duplications associated with reduced AUD risk across biologically unrelated sets, suggesting a global duplication dosage effect rather than pathway-specific enrichment. In contrast, deletion count within a Neurof_UnionStringent gene set was associated with increased AUD risk (OR=1.04, FDR=0.044), and deletions in xenobiotic-response genes showed nominal associations in multiple ancestry groups. Among rCNV of all sizes, a 58 bp deletion at 16p12.1, a dosage-sensitive neuropsychiatric locus, was significant in the cross-ancestry analysis (OR=2.93, FDR=0.030) without significant heterogeneity. rCNV detectable by srWGS do not appear to contribute substantially to AUD liability at current sample sizes.
- Open Access
- 9 February 2023
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 191 (5) , 1465-1469
Eighth case of Li‐Campeau syndrome in a Turkish patient caused by a novel pathogenic variant in UBR7 and expanding the phenotype
Li‐Campeau syndrome (LICAS) is an autosomal recessive disorder characterized by developmental delay, intellectual disability, genital anomalies, congenital heart defects, and dysmorphic features. LICAS is caused by biallelic pathogenic variants in the UBR7 gene, acting as an E3 ubiquitin‐protein ligase. Using exome sequencing (ES), we identified a homozygous novel pathogenic splice site variation c.1185+1G>C in UBR7 in a 32‐month‐old male from a nonconsanguineous Turkish family with clinical features of LICAS. Sanger sequencing revealed the heterozygous state of parents for this variant and confirmed the co‐segregation study. The variant may lead to the loss of function of UBR7 and is in a highly conserved residue. Bioinformatic prediction analysis using in silico algorithms supports the pathogenic effect of the splice site variant in the UBR7.
- 9 February 2023
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 191 (5) , 1465-1469
Open AccessEighth case of Li‐Campeau syndrome in a Turkish patient caused by a novel pathogenic variant in UBR7 and expanding the phenotype
Li‐Campeau syndrome (LICAS) is an autosomal recessive disorder characterized by developmental delay, intellectual disability, genital anomalies, congenital heart defects, and dysmorphic features. LICAS is caused by biallelic pathogenic variants in the UBR7 gene, acting as an E3 ubiquitin‐protein ligase. Using exome sequencing (ES), we identified a homozygous novel pathogenic splice site variation c.1185+1G>C in UBR7 in a 32‐month‐old male from a nonconsanguineous Turkish family with clinical features of LICAS. Sanger sequencing revealed the heterozygous state of parents for this variant and confirmed the co‐segregation study. The variant may lead to the loss of function of UBR7 and is in a highly conserved residue. Bioinformatic prediction analysis using in silico algorithms supports the pathogenic effect of the splice site variant in the UBR7.
- Open Access
- 23 August 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (8) , e04520
A novel biallelic LMNB2 variant in a patient with progressive myoclonus epilepsy and ataxia: A case of laminopathy
The report of LMNB2‐related progressive myoclonus epilepsy and ataxia due to missense homozygous c.473G>T variant.
- 23 August 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (8) , e04520
Open AccessA novel biallelic LMNB2 variant in a patient with progressive myoclonus epilepsy and ataxia: A case of laminopathy
The report of LMNB2‐related progressive myoclonus epilepsy and ataxia due to missense homozygous c.473G>T variant.
- Open Access
- 11 March 2020
- Published by S. Karger AG in Molecular Syndromology
- Vol. 11 (2) , 62-72
Whole-Exome Sequencing Identifies Three Candidate Homozygous Variants in a Consanguineous Iranian Family with Autism Spectrum Disorder and Skeletal Problems
Autism spectrum disorder (ASD) is characterized by 3 core symptoms with impaired social communication, repetitive behavior, and/or restricted interests in early childhood. As a complex neurodevelopmental disorder (NDD), the phenotype and severity of autism are extremely heterogeneous. Genetic factors have a key role in the etiology of autism. In this study, we investigated an Azeri Turkish family with 2 ASD-affected individuals to identify probable ASD-causing variants. First, the affected individuals were karyotyped in order to exclude chromosomal abnormalities. Then, whole-exome sequencing was carried out in one affected sibling followed by cosegregation analysis for the candidate variants in the family. In addition, SNP genotyping was carried out in the patients to identify possible homozygosity regions. Both proband and sibling had a normal karyotype. We detected 3 possible causative variants in this family: c.5443G>A; p.Gly1815Ser, c.1027C>T; p.Arg343Trp, and c.382A>G; p.Lys128Glu, which are in the FBN1, TF, and PLOD2 genes, respectively. All of the variants cosegregated in the family, and SNP genotyping revealed that these 3 variants are located in the homozygosity regions. This family serves as an example of a multimodal polygenic risk for a complex developmental disorder. Of these 3 genes, confluence of the variants in FBN1 and PLOD2 may contribute to the autistic features of the patient in addition to skeletal problems. Our study highlights the genetic complexity and heterogeneity of NDDs such as autism. In other words, in some patients with ASD, multiple rare variants in different loci rather than a monogenic state may contribute to the development of phenotypes.
- 11 March 2020
- Published by S. Karger AG in Molecular Syndromology
- Vol. 11 (2) , 62-72
Open AccessWhole-Exome Sequencing Identifies Three Candidate Homozygous Variants in a Consanguineous Iranian Family with Autism Spectrum Disorder and Skeletal Problems
Autism spectrum disorder (ASD) is characterized by 3 core symptoms with impaired social communication, repetitive behavior, and/or restricted interests in early childhood. As a complex neurodevelopmental disorder (NDD), the phenotype and severity of autism are extremely heterogeneous. Genetic factors have a key role in the etiology of autism. In this study, we investigated an Azeri Turkish family with 2 ASD-affected individuals to identify probable ASD-causing variants. First, the affected individuals were karyotyped in order to exclude chromosomal abnormalities. Then, whole-exome sequencing was carried out in one affected sibling followed by cosegregation analysis for the candidate variants in the family. In addition, SNP genotyping was carried out in the patients to identify possible homozygosity regions. Both proband and sibling had a normal karyotype. We detected 3 possible causative variants in this family: c.5443G>A; p.Gly1815Ser, c.1027C>T; p.Arg343Trp, and c.382A>G; p.Lys128Glu, which are in the FBN1, TF, and PLOD2 genes, respectively. All of the variants cosegregated in the family, and SNP genotyping revealed that these 3 variants are located in the homozygosity regions. This family serves as an example of a multimodal polygenic risk for a complex developmental disorder. Of these 3 genes, confluence of the variants in FBN1 and PLOD2 may contribute to the autistic features of the patient in addition to skeletal problems. Our study highlights the genetic complexity and heterogeneity of NDDs such as autism. In other words, in some patients with ASD, multiple rare variants in different loci rather than a monogenic state may contribute to the development of phenotypes.